Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
US Stock MarketDetailed Quotes
ESCA Escalade
- 15.780
- +0.480+3.14%
Close Apr 1 16:00 ET
- 15.780
- 0.0000.00%
Post 16:00 ET
215.74MMarket Cap16.97P/E (TTM)
16.070High15.460Low28.09KVolume15.460Open15.300Pre Close444.19KTurnover0.28%Turnover Ratio16.97P/E (Static)13.67MShares16.82052wk High1.28P/B158.45MFloat Cap11.94452wk Low0.60Dividend TTM10.04MShs Float22.139Historical High3.80%Div YieldTTM3.99%Amplitude0.064Historical Low15.814Avg Price1Lot Size
Escalade Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -25.41%36.05M | -40.40%12.29M | -29.37%10.46M | 58.62%13.29M | -99.84%7K | 463.59%48.33M | 44.04%20.62M | 370.85%14.81M | 222.56%8.38M | 257.24%4.52M |
| Net income from continuing operations | 32.12%12.99M | -5.73%2.7M | 32.56%5.67M | -21.91%2.84M | 286.45%1.78M | -45.36%9.83M | 5.92%2.86M | 44.52%4.28M | -35.80%3.64M | -114.31%-952K |
| Operating gains losses | -190.62%-1.72M | 12.68%2.13M | ---3.91M | ---13K | --67K | -2.82%1.9M | -4.10%1.89M | ---- | ---- | ---- |
| Depreciation and amortization | 6.52%6.04M | -6.90%1.35M | 36.33%1.94M | -1.71%1.38M | -1.65%1.37M | -6.47%5.67M | 69.39%1.45M | -11.28%1.42M | -34.18%1.4M | -5.23%1.4M |
| Deferred tax | 112.72%177K | ---- | ---- | ---- | ---- | -470.08%-1.39M | ---- | ---- | ---- | ---- |
| Other non cash items | ---- | ---- | ---- | ---- | -206.81%-3.86M | ---- | ---- | --0 | 47.27%-3.22M | 131.46%3.61M |
| Change In working capital | -43.09%17.82M | -57.41%7.19M | -28.71%6.01M | ---- | ---- | 280.52%31.31M | --16.87M | --8.43M | ---- | ---- |
| -Change in receivables | -93.16%470K | ---- | ---- | ---- | ---- | -29.48%6.87M | ---- | ---- | ---- | ---- |
| -Change in inventory | -44.11%16.44M | ---- | ---- | ---- | ---- | 285.58%29.41M | ---- | ---- | ---- | ---- |
| -Change in prepaid assets | -329.26%-1.72M | ---- | ---- | ---- | ---- | -78.09%752K | ---- | ---- | ---- | ---- |
| -Change in payables and accrued expense | 146.06%2.63M | ---- | ---- | ---- | ---- | 61.01%-5.72M | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -25.41%36.05M | -40.40%12.29M | -29.37%10.46M | 58.62%13.29M | -99.84%7K | 463.59%48.33M | 44.04%20.62M | 370.85%14.81M | 222.56%8.38M | 257.24%4.52M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 302.01%3.93M | 9.42%-346K | 1,182.22%5.36M | -112.91%-775K | 56.39%-307K | 94.86%-1.95M | -19.75%-382K | -129.17%-495K | 81.30%-364K | 98.01%-704K |
| Net PPE purchase and sale | 302.01%3.93M | 9.42%-346K | 1,182.22%5.36M | -112.91%-775K | 56.39%-307K | 6.08%-1.95M | -19.75%-382K | -129.17%-495K | 54.84%-364K | 3.56%-704K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 302.01%3.93M | 9.42%-346K | 1,182.22%5.36M | -112.91%-775K | 56.39%-307K | 94.86%-1.95M | -19.75%-382K | -129.17%-495K | 81.30%-364K | 98.01%-704K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 28.88%-35.8M | 61.33%-8.18M | -12.74%-15.75M | 7.89%-12.44M | 133.06%567K | -274.49%-50.33M | -50.69%-21.14M | -500.49%-13.97M | -1,492.33%-13.5M | -104.26%-1.72M |
| Net issuance payments of debt | 42.48%-25.3M | 81.55%-3.9M | -14.76%-13.67M | 8.11%-10.36M | 664.53%2.63M | -217.79%-43.99M | -78.72%-21.14M | -315.50%-11.91M | -1,047.31%-11.27M | -99.19%344K |
| Net common stock issuance | ---2.19M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash dividends paid | -34.40%-8.31M | ---2.08M | -1.07%-2.08M | -0.87%-2.08M | -0.19%-2.06M | 24.21%-6.18M | --0 | -1.03%-2.06M | -1.13%-2.06M | -1.03%-2.06M |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | 50.58%-169K | --0 | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 28.88%-35.8M | 61.33%-8.18M | -12.74%-15.75M | 7.89%-12.44M | 133.06%567K | -274.49%-50.33M | -50.69%-21.14M | -500.49%-13.97M | -1,492.33%-13.5M | -104.26%-1.72M |
| Net cash flow | ||||||||||
| Beginning cash position | -99.60%16K | -53.65%426K | -37.26%362K | -95.33%283K | -99.60%16K | -9.30%3.97M | -77.03%919K | -90.69%577K | -5.13%6.06M | -9.30%3.97M |
| Current changes in cash | 205.75%4.18M | 517.28%3.77M | -81.29%64K | 101.44%79K | -87.27%267K | -870.76%-3.95M | -2,636.36%-903K | 115.58%342K | -2,685.28%-5.49M | 3.91%2.1M |
| End cash Position | 26,112.50%4.19M | 26,112.50%4.19M | -53.65%426K | -37.26%362K | -95.33%283K | -99.60%16K | -99.60%16K | -77.03%919K | -90.69%577K | -5.13%6.06M |
| Free cash flow | -26.45%34.01M | -41.64%11.73M | -29.06%10.15M | 55.63%12.48M | -109.18%-350K | 615.39%46.24M | 43.63%20.11M | 350.00%14.31M | 347.32%8.02M | 205.83%3.81M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
